Columbia, MD — May 13, 2025
QNova LifeSciences and Liberi Group are pleased to announce the signing of an exclusive agreement to provide mutual referral consultancy services, effective May 1, 2025. This strategic collaboration reflects both organizations’ commitment to delivering world-class expertise and innovation in the life sciences and the professional services sectors.
Under the terms of the agreement, Liberi Group and QNova LifeSciences (formerly known as CSSi LifeSciences) will work closely together to leverage their combined knowledge, networks, and operational strengths, foster enhanced value creation for clients and stakeholders across both organizations.
“We are delighted to formalize our relationship with QNova LifeSciences through this exclusive consultancy agreement,” said Frans Trouwen, Founder, CEO and Chairman of the Board of Liberi Group.
“This partnership marks a significant milestone in our growth strategy, enabling us to broaden our reach and enhance the quality of services we offer.”
Jim Sergi, President of QNova LifeSciences added, “Our collaboration with the Liberi Group underscores our shared vision for excellence and innovation.”
“Together, we will be uniquely positioned to meet the evolving needs of our clients with a fully integrated and forward-thinking approach.”
The agreement will initially focus on joint referral consultancy initiatives across the global life sciences field whereas Liberi Group will provide the Business Development Services and Valuation Services and QNova LifeSciences will provide the Regulatory Services, with future opportunities for expanded collaboration already under discussion.
About Liberi Group
Liberi Group is a global Life Sciences Consultancy Firm with subsidiaries in both Europe and South Korea providing Business Development Services, Valuation Services and Investment Search for biotech companies.
About QNova Life Sciences
QNova LifeSciences is a global, innovative regulatory consulting group, specializing in advancing therapeutics and medical devices through development and regulatory approval. Our integrated model provides optimum value-creation for early-stage and emerging growth companies.
For media inquiries or if you are interested in learning more about our combined services, please contact:
Jim Sergi | President & Founder
info@qnovals.com
QNovaLS.com
6751 Columbia Gateway Drive, Suite 300, Columbia, MD 21046
www.linkedin.com/in/jim-sergi/